Skip to main content
. 2012 Aug 3;7(8):e42134. doi: 10.1371/journal.pone.0042134

Table 6. Liver, spleen and epididymal fat weights, liver TG and plasma total PAI-1 at the end of treatment.

Treatment Liver weight (g) Liver TG (mg/g tissue) Epididymal fat (g) Spleen weight (g) Plasma total PAI-1(pg/mL)
Lean Veh 1.82±0.05* 15±1* 1.17±0.07* 0.080±0.007 837±93*
DIO Veh 2.39±0.16 87±5 2.17±0.21 0.087±0.004 1722±244
CB1R ASO25 mg/kg/wk 1.97±0.09* 40±6* 1.99±0.16 0.138±0.009* 2765±327*
CB1R ASO12.5 mg/kg/wk 2.26±0.12 71±8 1.94±0.22 0.121±0.024 2145±278
CB1R ASO6.25 mg/kg/wk 2.21±0.10 81±12 2.08±0.15 0.093±0.003 1357±96
Control ASO25 mg/kg/wk 2.06±0.11 69±4 2.18±0.13 0.076±0.004 1180±83

Values shown are mean ± se. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.